2014Chinese Journal of General PracticeRequires access

Relationship between expressions of ErbB oncogene family and clinicopathologic features in breast cancer

Lipin Liu

Open publisher page 0 citations

Abstract

Objective To study the expression of oncogene erbB-1,erbB-2,erbB-3,erbB-4 in breast cancer and its value for prognosis. Methods The protein expression of erbB-1,erbB-2,erbB-3 and erbB-4 in 81 cases of breast cancer were examined by using paraffin-section immunohistochemistry. Results The patients were grouped by histological type,histological grade,lymph node metastasis and postoperative survival period. The difference in the positive rate of erbB-2 and 3 was significant among the histological grade,postoperative survival period and lymph node metastasis,respectively( P 0. 05 or P 0. 01),but not with histology type( P 0. 05); There was no statistical difference in the expression of erbB-1 and 4 among the four groups( P 0. 05); But the expression of erbB-2 compared to erbB-1,3 and 4 was obvious difference( P 0. 05 or P 0. 01). Conclusion The expression of erbB-2 and 3 were closely related to breast cancer growth, proliferation and metastasis,and can be regarded as an independent prognostic indicator; the expression of erbB-1,4 is synergistic in breast cancer growth. To analyze the expression of erbB-1 and 4 is valuable for the clinical diagnosis and treatment of breast cancer.

About this research paper

What this paper is about

Objective To study the expression of oncogene erbB-1,erbB-2,erbB-3,erbB-4 in breast cancer and its value for prognosis. Methods The protein expression of erbB-1,erbB-2,erbB-3 and erbB-4 in 81 cases of breast cancer were examined by using paraffin-section immunohistochemistry. Results The patients were grouped by histological type,histological grade,lymph node metastasis and postoperative survival period. The difference in the positive rate of erbB-2 and 3 was significant among the histological grade,postoperative survival period and lymph node metastasis,respectively( P 0. 05 or P 0. 01),but not with histology type( P 0. 05); There was no statistical difference in the expression of erbB-1 and 4 among the four groups( P 0. 05); But the expression of erbB-2 compared to erbB-1,3 and 4 was obvious difference( P 0. 05 or P 0. 01). Conclusion The expression of erbB-2 and 3 were closely related to breast cancer growth, proliferation and metastasis,and can be regarded as an independent prognostic indicator; the expression of erbB-1,4 is synergistic in breast cancer growth. To analyze the expression of erbB-1 and 4 is valuable for the clinical diagnosis and treatment of breast cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the expression of oncogene erbB-1,erbB-2,erbB-3,erbB-4 in breast cancer and its value for prognosis. Methods The protein expression of erbB-1,erbB-2,erbB-3 and erbB-4 in 81 cases of breast cancer were examined by using paraffin-section immunohistochemistry. Results The patients were grouped by histological type,histological grade,lymph node metastasis and postoperative survival period. The difference in the positive rate of erbB-2 and 3 was significant among the histological grade,postoperative survival period and lymph node metastasis,respectively( P 0. 05 or P 0. 01),but not with histology type( P 0. 05); There was no statistical difference in the expression of erbB-1 and 4 among the four groups( P 0. 05); But the expression of erbB-2 compared to erbB-1,3 and 4 was obvious difference( P 0. 05 or P 0. 01). Conclusion The expression of erbB-2 and 3 were closely related to breast cancer growth, proliferation and metastasis,and can be regarded as an independent prognostic indicator; the expression of erbB-1,4 is synergistic in breast cancer growth. To analyze the expression of erbB-1 and 4 is valuable for the clinical diagnosis and treatment of breast cancer.

Key concepts: Medicine, Breast cancer, Immunohistochemistry, ErbB, Lymph node, Metastasis, Oncology, Oncogene

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship between expressions of ErbB oncogene family and clinicopathologic features in breast cancer — Research Paper | ScholarLens